Zak Mir takes a charting look at some of the most followed small caps on the London stock market. Today’s charts are FTSE 100, Dax, Dow, Bitcoin, African Pioneer, Arc, Biome,
N4 Pharma PLC (AIM:N4P) siRNA update
N4 Pharma Plc (AIM: N4P), the specialist pharmaceutical company developing Nuvec®, a novel delivery system for cancer treatments and vaccines, is pleased to provide a further update on its ongoing
N4 Pharma’s share price has risen due to positive developments related to Nuvec
N4 Pharma PLC’s (AIM: N4P) shares have risen by more than 7% following the biotech firm’s announcement that it has successfully completed the single loading of EGFR and BCL-2 siRNA
Traders Cafe with Zak Mir: Bulletin Board Heroes, Sunday 12th February 2023 via Vox Markets
Zak Mir takes a charting look at some of the most followed small caps on the London stock market. Today’s charts are FTSE 100, Dax, Dow, Bitcoin, Aeroema, Cizzle, Chill,
Traders Cafe with Zak Mir: Bulletin Board Heroes, Wednesday 19th October 2022 via Vox Markets
Zak Mir takes a charting look at some of the most followed small caps on the London stock market. Today’s selection of charts is FTSE 100, Baron Oil, Bezant Resources,
Traders Cafe “Bank Holiday Edition” with Zak Mir: Bulletin Board Heroes, Sunday 16th October 2022 via Vox Markets
Zak Mir takes a charting look at some of the most followed small caps on the London stock market. Today’s selection of charts is FTSE 100, Pound/Dollar, Boston International Holdings,
Traders Cafe “Bank Holiday Edition” with Zak Mir: Bulletin Board Heroes, Sunday 9th October 2022 via Vox Markets
Zak Mir takes a charting look at some of the small caps stocks of the week on the London stock market. Today’s selection of charts is FTSE 100, Pound /
N4 Pharma PLC (AIM:N4P) Double siRNA Testing Update
N4 Pharma Plc (AIM: N4P), the specialist pharmaceutical company developing Nuvec®, a novel delivery system for cancer treatments and vaccines, is pleased to announce successful in vitro testing of Nuvec®
N4 Pharma PLC (AIM:N4P) Operational Update
N4 Pharma Plc (AIM: N4P), the specialist pharmaceutical company developing Nuvec®, a novel delivery system for cancer treatments and vaccines, is pleased to provide an operational update on its development
N4 Pharma PLC (AIM:N4P) Work Programme Update
N4 Pharma Plc (AIM: N4P), the specialist pharmaceutical company developing Nuvec®, a novel delivery system for cancer treatments and vaccines, is pleased to announce a further update on its recent
RNS Hotlist with Zak Mir: AGL, NCYT, TOM, N4P, TYM, NCCL, AYM & SDX via Vox Markets
ANGLE (AGL), a liquid biopsy company, announced the completion of the placing announced on 14 July 2022 to raise £20 million, together with a subscription in the capital of the